COPENHAGEN (Reuters) -Denmark said on Friday Danish life science companies are challenged by U.S. President Donald Trump’s executive order on Monday that directs drugmakers to lower drug prices.
The wide-reaching order gives drugmakers price targets in the next 30 days. The U.S. administration has said it will take further action to lower prices if companies do not make “significant progress” toward the goals.
“There is no doubt that what Donald Trump has said about pharmaceuticals is just another step in the wrong direction,” Danish Business Minister Morten Bodskov told reporters on Friday.
“It creates more uncertainty, it creates new barriers to our trade and it is in every way the wrong way to go,” he said.
(Reporting by Isabelle Yr Carlsson and Louise Breusch Rasmussen, editing by Anna Ringstrom)
Comments